Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia.

Saved in:
Bibliographic Details
Title: Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia.
Authors: Graham-Clarke PL; Global Patient Outcomes and Real World Evidence, Eli Lilly Australia, West Ryde, NSW 2114, Australia., Hauber B; Health Preference Assessment Group, RTI Health Solutions, Research Triangle Park, NC 27709, USA., Boeri M; Health Preference Assessment Group, RTI Health Solutions, Belfast BT2 8LA, UK., Leonardi F; Eli Lilly Interamerica Inc, Bogotá, Colombia., Burge RT; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co, Lilly Corporate Center, Indianapolis, IN 46285, USA., Fernandez M; Health Preference Assessment Group, RTI Health Solutions, Research Triangle Park, NC 27709, USA., Tockhorn-Heidenreich A; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co, Erl Wood Manor, Surrey GU20 6PH, UK., Florez S; Eli Lilly Interamerica Inc, Bogotá, Colombia.; Pain and Palliative Care Unit, Universidad De La Sabana, Bogotá, Colombia.
Source: Patient preference and adherence [Patient Prefer Adherence] 2020 Jun 23; Vol. 14, pp. 1049-1064. Date of Electronic Publication: 2020 Jun 23 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475748 Publication Model: eCollection Cited Medium: Print ISSN: 1177-889X (Print) Linking ISSN: 1177889X NLM ISO Abbreviation: Patient Prefer Adherence Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1177-889X
DOI:10.2147/PPA.S250745